Research from Dubai Hospital Yields New Findings on Hypovolemia [Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review].

MLA

“Research from Dubai Hospital Yields New Findings on Hypovolemia [Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review].” Diabetes Week, Nov. 2024, p. 302. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180601989&authtype=sso&custid=ns315887.

APA

Research from Dubai Hospital Yields New Findings on Hypovolemia [Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review]. (2024). Diabetes Week, 302.

Chicago

“Research from Dubai Hospital Yields New Findings on Hypovolemia [Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review].” 2024. Diabetes Week, November, 302. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180601989&authtype=sso&custid=ns315887.